By correcting TP53-R273H and TP53-R175H mutations in cancer cell lines derived from diverse tissues, we were able to uncover both the phenotypic dependencies on mutant TP53 expression and the restoration of conserved tumor-suppressive transcriptional programs upon correction. The gene discussed is TP53; the disease is neoplasm.